Efficacy and safety of azilsartan medoxomil in the treatment of hypertension: a systematic review and meta-analysis
BackgroundAngiotensin II receptor blockers (ARBs) are utilized for the management of hypertension and diabetes. Previous meta-analyses suggested that azilsartan medoxomil (AZL-M) improved blood pressure (BP) reduction, but there were no safety findings or suggestions for patients with hypertension o...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2024-07-01
|
| Serier: | Frontiers in Cardiovascular Medicine |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1383217/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
